Rho Acquires Dokumeds

Rho has announced that they have acquired Dokumeds, a privately-held European CRO. Established in 1995 and headquartered in Riga, Latvia, Dokumeds has 10 offices and is active across multiple continents. Terms were not disclosed.

The combined companies will continue to provide full service clinical development services, from investigational new drug applications to regulatory submissions.

Edgemont Partners served as the exclusive financial advisor to Rho on the transaction.